The global pandemic involving severe acute respiratory syndrome–coronavirus-2 (SARS-COV-2) has stretched the limits of science. Ever since it emerged from the Wuhan province in China, it has spread across the world and has been fatal to about 4% of the victims. This position statement of the Indian Society of Critical Care Medicine represents the collective opinion of the experts chosen by the society.
Farmer JC, Wax RS, Baldisseri MR, ed., Preparing Your ICU for Disaster Response. Society of Critical Care Medicine.
Infection prevention and control when novel coronavirus infection is suspected. Interim Guidance. WHO (https://www.who.int/publications-detail/infection-prevention-and-control-during-health-care-when-novel-coronavirus-(ncov)-infection-is-suspected-20200125) Accessed on 16/03/2020.
COVID-19. Guidance for infection prevention and control in healthcare settings. Public Health England (https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/872745/Infection_prevention_and_control_guidance_for_pandemic_coronavirus.pdf).
Interim infection prevention and control recommendation for patients with COVID-19 in healthcare settings (https://www.cdc.gov/coronavirus/2019-ncov/infection-control/control-recommendations.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Fhcp%2Finfection-control.html) Accessed on 16/03/2020.
The Australian and New Zealand Intensive Care Society Guidelines COVID-19. (https://www.anzics.com.au/wp-content/uploads/2020/03/ANZICS-COVID-19-Guidelines-Version-1.pdf).
Arabi YM, Murthy S, Webb S. COVID-19: a novel coronavirus and a novel challenge for critical care. Intensive Care Med 2020. 1–4. DOI: 10.1007/s00134-020-05955-1.
Jin Y, Cai L, Cheng Z, Cheng H, Deng T, Fan YP, et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Military Med Res 2020;7(4). DOI: 10.1186/s40779-020-0233-6.
Bouadma L, Lescure F, Lucet JC, Yazdanpanah Y, Timsit JF, et al. Severe SARS-CoV-2 infections: practical considerations and management strategy for intensivists. Intensive Care Med 2020;46:579–582. DOI: https://doi.org/10.1007/s00134-020-05967.
Annexure-How to convert a room to negative pressure room.
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA 2020;323(11):1061–1069.
Hosseiny M, Kooraki S, Gholamrezanezhad A, Reddy S, Myers L. Radiology perspective of coronavirus disease 2019 (COVID-19): lessons from severe acute respiratory syndrome and middle east respiratory syndrome. AJR Am J Roentgenol 2020. 1–5.
Yoon SH, Lee KH, Kim JY, Lee YK, Ko H, Kim KH, et al. Chest radiographic and CT findings of the 2019 novel coronavirus disease (COVID-19): analysis of nine patients treated in Korea. Korean J Radiol 2020;21(4):494–500.
Shi H, Han X, Jiang N, Cao Y, Alwalid O, Gu J, et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis 2020;20(4):P425–P434.
Song F, Shi N, Shan F, Zhang Z, Shen J, Lu H, et al. Emerging 2019 novel coronavirus (2019-nCoV) pneumonia. Radiology 2020;295(1): 210–217.
Peng Q, Wang X, Zhang L. Findings of lung ultrasonography of novel corona virus pneumonia during the 2019–2020 epidemic. Intensive Care Med 2020. DOI: 10.1007/s00134-020-05996-6.
Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med 2020. 1–3.
Liu J, Liu Y, Xiang P, Pu L, Xiong H, Li C, Zhang M, et al. Neutrophil-to-lymphocyte ratio predicts severe illness patients with 2019 novel coronavirus in the early stage 10.1101/2020.02.10. 20021584.
Sheahan TP, Sims AC, Leist SR, Schäfer A, Won J, Brown AJ, et al. Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV. Nat Commun 2020;11(1):222.
Chu CM, Cheng VC, Hung IF, Wong MM, Chan KH, Chan KS, et al. Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax 2004;59(3):252–256.
Chan KS, Lai ST, Chu CM, Tsui E, Tam CY, Wong MM, et al. Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study. Hong Kong Med J 2003;9(6):399–406.
Park SY, Lee JS, Son JS, Ko JH, Peck KR, Jung Y, et al. Post-exposure prophylaxis for middle east respiratory syndrome in healthcare workers. J Hospital Infect 2019;101:42–46.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395(10223):497–506.
Chen N, Zhou M, Dong X, Qu J, Gong F, Han, Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020;395(10223):507–513.
Sun P, Qie S, Liu Z, Ren J, Li K, Xi J. Clinical characteristics of 50466 hospitalized patients with 2019-nCoV infection. J Med Virol 2020.
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult in patients with COVID-19 in Wuhan, China: a retrospective cohort study. 2020;395(10229):1054–1062. DOI: 10.1016/S0140-6736(20)30566-3.
Xu L, Liu J, Lu M, Yang D, Zheng X. Liver injury during highly pathogenic human coronavirus infections. Liver Int 2020.
European Centre for Disease Prevention and Control. Checklist for hospitals preparing for the reception and care of coronavirus 2019 (COVID-19) patients. ECDC: Stockholm; 2020.
European Centre for Disease Prevention and Control. Discharge criteria for confirmed COVID 19 cases. When is it safe to discharge COVID 19 cases from the hospital or end home Isolation? ECDC: Stockholm; 2020.
World Health Organization. Report of WHO China Joint Mission Coronavirus Disease 2019. COVID 19, Geneva. Available from: https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf.
Zhang W, Du R-H, Li B, Zheng X-S, Yang X-L, Hu B, et al. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes. Emerg Microbes & Infect 2020;9(1):386–389.
Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z, et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. New England J Med 2020.
Bai Y, Yao L, Wei T, Tian F, Jin D-Y, Chen L, et al. Presumed asymptomatic carrier transmission of COVID-19. JAMA 2020.
Tay J-Y, Lim PL, Marimuthu K, Sadarangani SP, Min Ling Li, Peng Ang BS, et al. De-isolating COVID-19 suspect cases: a continuing challenge. Clin Infect Diseas 2020. DOI: https://doi.org/10.1093/cid/ciaa17.
Coronavirus Disease 2019, World Health Organisation. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public.
Schwartz J, King CC, Yen MY. Protecting health care workers during the COVID-19 coronavirus outbreak -lessons from Taiwan's SARS response. clinical infectious diseases: an official publication of the infectious diseases society of America 10.1093/cid/ciaa255.
Wax RS, Christian MD. Practical recommendations for critical care and anaesthesiology teams caring for novel corona virus (2019–nCoV) patients. Can J of Anaes 2020.